» Articles » PMID: 36248357

Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy

Overview
Journal J Thyroid Res
Publisher Wiley
Specialty Endocrinology
Date 2022 Oct 17
PMID 36248357
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone turnover markers (BTMs) have emerged as a useful tool for monitoring bone remodeling activity in the skeleton, and their serum levels correlate with bone loss rates in osteoporotic and normal individuals. Whether the same holds for other metabolic bone diseases is still subject to discussion.

Methods: We analyzed the relation between levels of BTMs and TSH in 79 females on thyroid hormone substitution therapy for hypothyroidism. Based on the reference range for TSH (0.2-4.0 mU/L) in our lab, we assessed BTMs in five different groups of patients based on the following criteria: (1) hypothyroidism (TSH >4.0); (2) TSH in the high normal range (1.0-4.0); (3) TSH in the low normal range (0.2-1.0); (4) TSH below the normal range (0.01-0.2); (5) TSH undetectable (<0.01). We studied the relationship between TSH and four different bone markers: procollagen type 1 N-terminal propeptide (PINP), C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), and bone specific alkaline phosphatase (BSAP). In a subgroup of patients, bone mineral density was assessed by a DXA scan.

Results: PINP emerged as the most sensitive and dynamic BTM for assessment of bone turnover in this patient group, achieving significant rho values on nonparametric correlation analysis for both TSH (rho -0.47; =0.0001) and FT4 (rho 0.27; =0.018). CTX and OC also revealed significant correlations to TSH, albeit with lower rho values (-0.37 and -0.24, respectively). Categorical analysis showed that bone turnover increased significantly, albeit with pronounced interindividual variability for TSH values below the lower limit of normal (0.2 mU/l), with the most severe affected being women exhibiting suppression of TSH. Further analysis of loss rates by DXA in a limited subgroup of patients showed that this was accompanied by accelerated bone loss.

Conclusion: PINP is the most sensitive marker of bone turnover in thyroid disorders. TSH values below the lower limit of normal are associated with increased bone turnover and accelerated bone loss, however, with pronounced interindividual variations. Assessment of PINP may be a valuable tool in cases where there is concern about possible adverse effects of thyroid hormone substitution therapy on bone.

Citing Articles

Radiomorphometric Parameters in Mandibular Panoramic Radiographs of Hypothyroid Patients: A Cross-Sectional Study.

Nair A, Patil V, Bhardwaj I, Singhal D, Smriti K, Chhaparwal Y Clin Cosmet Investig Dent. 2025; 17():31-37.

PMID: 39830592 PMC: 11742241. DOI: 10.2147/CCIDE.S502528.


Causal relationship between thyroid dysfunction and hallux valgus: A two-sample Mendelian randomization study.

Xiong B, Bai Z, Cao X, Nie D, Zhang C, Sun X Front Endocrinol (Lausanne). 2023; 14:1115834.

PMID: 36967762 PMC: 10030973. DOI: 10.3389/fendo.2023.1115834.

References
1.
Szulc P . Biochemical bone turnover markers in hormonal disorders in adults: a narrative review. J Endocrinol Invest. 2020; 43(10):1409-1427. DOI: 10.1007/s40618-020-01269-7. View

2.
Parker W, Edafe O, Balasubramanian S . Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature. Pragmat Obs Res. 2017; 8:57-67. PMC: 5440065. DOI: 10.2147/POR.S130510. View

3.
Rodriguez E, Stuber M, Del Giovane C, Feller M, Collet T, Lowe A . Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study. J Clin Endocrinol Metab. 2019; 105(1). DOI: 10.1210/clinem/dgz058. View

4.
Schneider R, Schneider M, Reiners C, Schneider P . Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. J Clin Endocrinol Metab. 2012; 97(11):3926-34. DOI: 10.1210/jc.2012-2570. View

5.
Eriksen E . Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev. 1986; 7(4):379-408. DOI: 10.1210/edrv-7-4-379. View